» Articles » PMID: 31114908

Remodeling and Destabilization of Chromosome 1 Pericentromeric Heterochromatin by SSX Proteins

Overview
Specialty Biochemistry
Date 2019 May 23
PMID 31114908
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Rearrangement of the 1q12 pericentromeric heterochromatin and subsequent amplification of the 1q arm is commonly associated with cancer development and progression and may result from epigenetic deregulation. In many premalignant and malignant cells, loss of 1q12 satellite DNA methylation causes the deposition of polycomb factors and formation of large polycomb aggregates referred to as polycomb bodies. Here, we show that SSX proteins can destabilize 1q12 pericentromeric heterochromatin in melanoma cells when it is present in the context of polycomb bodies. We found that SSX proteins deplete polycomb bodies and promote the unfolding and derepression of 1q12 heterochromatin during replication. This further leads to segregation abnormalities during anaphase and generation of micronuclei. The structural rearrangement of 1q12 pericentromeric heterochromatin triggered by SSX2 is associated with loss of polycomb factors, but is not mediated by diminished polycomb repression. Instead, our studies suggest a direct effect of SSX proteins facilitated though a DNA/chromatin binding, zinc finger-like domain and a KRAB-like domain that may recruit chromatin modifiers or activate satellite transcription. Our results demonstrate a novel mechanism for generation of 1q12-associated genomic instability in cancer cells.

Citing Articles

Genetic and Molecular Heterogeneity of Synovial Sarcoma and Associated Challenges in Therapy.

Lesovaya E, Fetisov T, Bokhyan B, Maksimova V, Kulikov E, Belitsky G Cells. 2024; 13(20.

PMID: 39451213 PMC: 11506332. DOI: 10.3390/cells13201695.


Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancer.

Naik A, Lattab B, Qasem H, Decock J Mol Ther Oncol. 2024; 32(1):200768.

PMID: 38596293 PMC: 10876628. DOI: 10.1016/j.omton.2024.200768.


Antipsychotics Affect Satellite III (1q12) Copy Number Variations in the Cultured Human Skin Fibroblasts.

Ershova E, Savinova E, Kameneva L, Porokhovnik L, Veiko R, Salimova T Int J Mol Sci. 2023; 24(14).

PMID: 37511043 PMC: 10380077. DOI: 10.3390/ijms241411283.


Chromosomal Heteromorphisms and Cancer Susceptibility Revisited.

Liehr T Cells. 2022; 11(20).

PMID: 36291106 PMC: 9600968. DOI: 10.3390/cells11203239.


SSX addiction in melanoma propagates tumor growth and metastasis.

Traynor S, Ebstrup M, Gammelgaard O, Mansoori B, Terp M, Rein C Front Oncol. 2022; 12:998000.

PMID: 36276095 PMC: 9585237. DOI: 10.3389/fonc.2022.998000.


References
1.
Darcy P, Maruwge W, Wolahan B, Ma L, Brodin B . Oncogenic functions of the cancer-testis antigen SSX on the proliferation, survival, and signaling pathways of cancer cells. PLoS One. 2014; 9(4):e95136. PMC: 4005730. DOI: 10.1371/journal.pone.0095136. View

2.
Banito A, Li X, Laporte A, Roe J, Sanchez-Vega F, Huang C . The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma. Cancer Cell. 2018; 33(3):527-541.e8. PMC: 5881394. DOI: 10.1016/j.ccell.2018.01.018. View

3.
Guttenbach M, Schmid M . Exclusion of specific human chromosomes into micronuclei by 5-azacytidine treatment of lymphocyte cultures. Exp Cell Res. 1994; 211(1):127-32. DOI: 10.1006/excr.1994.1068. View

4.
Simon J, Kingston R . Mechanisms of polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol. 2009; 10(10):697-708. DOI: 10.1038/nrm2763. View

5.
Greve K, Pohl M, Olsen K, Nielsen O, Ditzel H, Gjerstorff M . SSX2-4 expression in early-stage non-small cell lung cancer. Tissue Antigens. 2014; 83(5):344-9. DOI: 10.1111/tan.12340. View